Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.

@article{Wang2014GolgiP7,
  title={Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.},
  author={Yichen Wang and Huayu Yang and Haifeng Xu and Xin Lu and Xinting Sang and Shouxian Zhong and Jiefu Huang and Yilei Mao},
  journal={Journal of gastroenterology and hepatology},
  year={2014},
  volume={29 3},
  pages={597-602}
}
BACKGROUND AND AIM This study aimed to evaluate the effectiveness of serum Golgi protein 73 (GP73) and Glypican-3 (GPC-3) as tumor markers for diagnosis of hepatocellular carcinoma (HCC). METHODS A total of 257 subjects were enrolled and consisted of 61 healthy controls, 32 hepatitis B virus carriers, 80 cirrhosis patients, and 84 HCC patients. Diagnosis was performed based on established clinical procedure. Serum GP73, GPC-3, and α-fetoprotein were measured. Receiving operating… CONTINUE READING
Highly Cited
This paper has 24 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…